Skip to content

Evaluation of the effect of wormwood on the symptoms of premenstrual syndrome

Evaluation of the effect of soft gel of wormwood on the symptoms of premenstrual syndrome:A randomized controlled trial

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20220311054255N1
Enrollment
100
Registered
2022-04-10
Start date
2022-04-04
Completion date
Unknown
Last updated
2022-05-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Premenstrual Syndrome. Premenstrual Syndrome

Interventions

Intervention procedure: Women 18-45 years old with symptoms of premenstrual syndrome according to similar studies of patients daily perl of wormwood (containing 1.2 grams of wormwood) made by Bu Ali D

Sponsors

Ghoum University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 45 Years

Inclusion criteria

Inclusion criteria: Patients with premenstrual syndrome for at least one year

Exclusion criteria

Exclusion criteria: Having any menstrual disorders, pregnancy, lactation. Having diseases of the musculoskeletal system, having acute infectious diseases, especially urinary tract, having inflammatory gastrointestinal diseases and active gastric ulcer, having any Heart, liver and kidney failure and a history of major depression. Any drug addiction

Design outcomes

Primary

MeasureTime frame
Reduction of symptoms associated with PMS. Timepoint: Within three months. Method of measurement: Patients in two different groups are selected randomly and the drug is given to the main group and monthly symptoms are checked and telephone follow-up is done to continue taking the drug.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMaryam Yousefi

Ghoum University of Medical Sciences

mary.yousefi321@gmail.com+98 25 3772 5223

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026